3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars

• Status: Not yet recruiting
• Trial end date: 2024-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This randomized clinical study aims to assess the clinical and radiographic success rate of the 3Mixtatin versus the 3Mix in LSTR in necrotic primary molars.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular; Simvastatin

Criteria

Inclusion Criteria:

• Pediatric patients aged 4-7 years.

• Positive parental informed consent.

• Restorable necrotic mandibular second primary molars with peri-radicular/furcal involvement and/or pathologic root resorption (external or internal).

• Presence of chronic apical abscess or sinus tract or furcation radiolucency. (Thakur et al., 2021)

Exclusion Criteria:

• Medically compromised children.

• Children with known allergy to any of the components being utilized.

• Molars near exfoliation.

• Molars with severely resorbed roots more than two thirds indicated for extraction

• Molars with insufficient coronal structure disabling proper coronal seal.

• Presence of periapical or interradicular radiolucent area which could compromise the permanent tooth bud. (Shetty et al., 2020)